Tarsus, UK based, private equity-owned exhibitions group, has added the final 50% of equity in its medical events JV and has also bought a new dermatology event. The events company has had a 50% stake in Hubei Hope Exhibitions since 2008 which included the Chengdu Dental Show and the Zhengzhou Medical and Dental Show.
China remains a fast-growth events market and one of the few able to operate at some level during the pandemic. Both of the events were able to take place in August this year.
Tarsus has other event interests in China including Hometex, Touch China and Music China. In its second acquisition, Tarsus has acquired the Masters of Paediatric Dermatology (MOPD) event to add to its existing medical portfolio. The next MOPD will take place in February 2021, both online and in-person. Terms not disclosed for either of the deals.
